Your browser doesn't support javascript.
loading
Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK).
Ghielmini, M; Rufibach, K; Salles, G; Leoncini-Franscini, L; Léger-Falandry, C; Cogliatti, S; Fey, M; Martinelli, G; Stahel, R; Lohri, A; Ketterer, N; Wernli, M; Cerny, T; Schmitz, S-F Hsu.
Afiliação
  • Ghielmini M; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. mghielmini@ticino.com
Ann Oncol ; 16(10): 1675-82, 2005 Oct.
Article em En | MEDLINE | ID: mdl-16030029
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2005 Tipo de documento: Article